Manufacturers Life Insurance Company, The X4 Pharmaceuticals, Inc Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$1.03 - $2.02 $100 - $197	-98 Reduced 0.19%	51,592 $56,000
Q2 2023 Aug 11, 2023	BUY	$0.82 - $2.49 $42,385 - $128,708	51,690 New	51,690 $100,000
Q2 2021 Aug 12, 2021	SELL	$6.49 - $9.56 $68,566 - $101,001	-10,565 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$6.63 - $10.28 $70,045 - $108,608	10,565 New	10,565 $91,000
Q4 2020 Feb 12, 2021	SELL	$5.41 - $7.4 $56,420 - $77,174	-10,429 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$7.98 - $10.44 $83,223 - $108,878	10,429 New	10,429 $89,000

107

101M

418K

71.7K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $45.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.